ID: ALA4866166

Max Phase: Preclinical

Molecular Formula: C11H14N4O3

Molecular Weight: 250.26

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ncc([N+](=O)[O-])n1CCOCc1ccc[nH]1

Standard InChI:  InChI=1S/C11H14N4O3/c1-9-13-7-11(15(16)17)14(9)5-6-18-8-10-3-2-4-12-10/h2-4,7,12H,5-6,8H2,1H3

Standard InChI Key:  XPWMMLKPCZYCIT-UHFFFAOYSA-N

Associated Targets(non-human)

Pancreatic alpha-amylase 211 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 250.26Molecular Weight (Monoisotopic): 250.1066AlogP: 1.64#Rotatable Bonds: 6
Polar Surface Area: 85.98Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.03CX LogP: 0.91CX LogD: 0.91
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.48Np Likeness Score: -1.69

References

1. Patel OPS, Jesumoroti OJ, Legoabe LJ, Beteck RM..  (2021)  Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.,  210  [PMID:33234343] [10.1016/j.ejmech.2020.112994]

Source